Select market-stage ATMPs price in the U.S. as of 2016

Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016 (in U.S. dollars)

by Matej Mikulic, last edited Apr 17, 2018
Select market-stage ATMPs price in the U.S. as of 2016 This statistic shows the price of select market-stage ATMPs, as of September 2016. At that moment, the price of ex-vivo gene therapy Strimvelis stood at 665,000 U.S. dollars.
Show more

Price of select market-stage advanced therapy medicinal products (ATMPs) as of 2016 (in U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Cell and gene therapy
Cell and gene therapy

All Information
in one Presentation

Cell and gene therapy

Everything On "Cell and gene therapy" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Cell and gene therapy"
  • Market overview
  • R&D/trials
  • Stem cells
  • Cord blood
  • CAR/CAR-T
  • Miscellaneous
The most important statistics
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.